Morgan Keegan Starts Coverage on 10 Healthcare Stocks: ABT, BSX, STJ at Outperform, JNJ, MDT at Market Perform

In the Healthcare group Friday morning, Morgan Keegan's Jan Wald initiated coverage on the following stocks:

• Abbott Labs (NYSE: ABT) with an Outperform rating and a $61 price target
  
• Boston Scientific (NYSE: BSX) with an Outperform rating and a $8 price target
  
• St. Jude (NYSE: STJ) with an Outperform rating and a $60 price target
  
• DexCom (Nasdaq: DXCM) with an Outperform rating and a $18 price target
  
• HeartWare (Nasdaq: HTWR) with an Outperform rating and a $87 price target
  
• J&J (NYSE: JNJ) with a Market Perform rating and a $70 price target
  
• Medtronic (NYSE: MDT) with a Market Perform rating and a $43 price target
  
• Edwards Lifesciences (NYSE: EW) with a Market Perform rating and a $97 price target
  
• Thoratec (Nasdaq: THOR) with a Market Perform rating and a $35 price target
  
• AtriCure (Nasdaq: ATRC) with a Market Perform rating and a $14 price target

Check out our Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)
• Wells Fargo Starts Vivmark Residential (VMRK) at Overweight, 'Setting the mark for growth'
• William Blair Starts Tandem Diabetes Care (TNDM) at Outperform